Related Experiment Video
Updated: Jul 5, 2025
09:44
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
164
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.
Sarah Cherkaoui1,2, Lifeng Yang3,4, Matthew McBride3,4
1Pediatric Cancer Metabolism Laboratory, Children's Research Center, University of Zurich, 8032 Zurich, Switzerland.
Biorxiv : the Preprint Server for Biology
|January 23, 2024
Summary
Dietary restriction combined with difluoromethylornithine (DFMO) targets neuroblastoma by depleting polyamines. This strategy disrupts oncogenic protein translation, promotes tumor differentiation, and improves survival in a mouse model.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- Neuroblastoma is a lethal pediatric cancer originating from undifferentiated neural crest cells.
- Cancer growth relies on metabolic pathways, including polyamine biosynthesis, which is crucial for neuroblastoma.
- Difluoromethylornithine (DFMO), a polyamine biosynthesis inhibitor, has shown clinical efficacy in neuroblastoma.
Conclusions:
- Combining dietary restriction with DFMO offers a novel therapeutic strategy for neuroblastoma by manipulating protein translation.
- Specific codon usage preferences in gene sets can be exploited for targeted translational rewiring in response to metabolic stress.
- This approach holds promise for activating differentiation and treating pediatric cancers.
